Wall Street analyst estimates for Fonar Corp. (FONR): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-05-11 | $0.24 | ||
| 2026-02-13 | $0.31 | ||
| 2025-11-10 | $0.34 | ||
| 2025-09-22 | $0.11 | ||
| 2025-05-15 | $0.37 | ||
| 2025-02-19 | $0.29 | ||
| 2024-11-12 | $0.46 | ||
| 2024-09-27 | $0.13 |
Valuation Ratios
| P/E Ratio | 18.90 |
| Price / Book | 0.66 |
| EV / EBITDA | 6.47 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $73.4M | $78.0M | $81.5M | $87.2M | $85.7M | $89.9M | $97.6M | $98.6M | $102.9M | $104.4M |
| Cost of Revenue | $38.9M | $38.1M | $42.0M | $44.0M | $43.3M | $46.5M | $50.6M | $52.9M | $57.7M | $61.4M |
| Gross Profit | $34.5M | $40.0M | $39.6M | $43.2M | $42.4M | $43.5M | $47.0M | $45.7M | $45.1M | $42.9M |
| Research & Development | $1.6M | $1.5M | $1.8M | $1.8M | $2.0M | $1.6M | $1.5M | $1.6M | $1.7M | $1.6M |
| Selling, General & Admin | $18.7M | $19.4M | $18.1M | $19.3M | 0 | 0 | 0 | $29.4M | 0 | $29.7M |
| Operating Expenses | $20.1M | $20.9M | $19.9M | $21.1M | $28.7M | $26.4M | $25.0M | $31.0M | $28.6M | $31.3M |
| Operating Income | $14.4M | $19.1M | $19.7M | $22.1M | $13.7M | $17.1M | $22.0M | $14.8M | $16.5M | $11.6M |
| EBITDA | $18.1M | $22.6M | $23.8M | $26.5M | $17.6M | $22.0M | $27.7M | $24.6M | $23.9M | $18.5M |
| Interest Expense | $262193 | 0 | $160074 | $98636 | $74321 | $248665 | $346552 | $50131 | $76997 | $25611 |
| Pre-tax Income | $14.5M | $19.3M | $19.8M | $22.5M | $14.1M | $17.7M | $22.8M | $15.8M | $19.3M | $13.8M |
| Income Tax | -$4.3M | -$4.4M | -$5.7M | $2.0M | $2.4M | $4.0M | $5.5M | $3.6M | $5.2M | $3.1M |
| Net Income | $15.7M | $19.6M | $21.2M | $15.3M | $8.2M | $10.2M | $12.4M | $9.4M | $10.6M | $8.3M |
| EPS | $2.43 | $2.98 | $3.38 | $3.18 | $1.79 | $1.47 | $1.78 | $1.35 | $1.56 | $1.26 |
| EPS (Diluted) | $2.38 | $2.92 | $3.31 | $3.11 | $1.75 | $1.45 | $1.75 | $1.32 | $1.53 | $1.23 |
| Shares Outstanding (Diluted) | $6.6M | $6.7M | $6.4M | $6.6M | $6.7M | $6.7M | $6.7M | $6.8M | $6.5M | $6.6M |
Price
| Price | $19.09 |
| Market Cap | $118M |
| Exchange | NASDAQ |
| Country | US |
Related companies: APYX · ARTV · EDAP · HYPR · IFRX · LUNG · NSPR
Explore sector: Healthcare · Medical - Equipment & Services
More sections of FONR: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks